Brief: Alzchem Q1 Group EBITDA Rose By 10% To EUR 27.4 MLN

AlzChem AG

30/04/2025 06:20

April 30 (Reuters) - ALZCHEM GROUP AG ACT1.DE:

Q1 GROUP EBITDA ROSE BY 10% TO EUR 27.4 MILLION DESPITE A 4% DECLINE IN SALES

FORECAST FOR FURTHER SALES AND EBITDA GROWTH IN 2025 CONFIRMED

GROUP SALES IN THE FIRST THREE MONTHS OF 2025 AT EUR 144.7 MILLION

CONFIRMS 2025 GUIDANCE, SEES EBITDA GROWING BY 7%

Q1 FREE CASH FLOW AT EUR 36.4 MILLION

SAYS US CUSTOMS POLICY HAS NOT HAD A NEGATIVE IMPACT SO FAR

Further company coverage: ACT1.DE

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))